PTC Therapeutics, Inc. which can be found using ticker (PTCT) have now 14 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The range between the high target price and low target price is between 71 and 37 suggesting an average Analsyt target price of $55.50. Given that the stocks previous close was at $58.13 this would indicate that there is a downside of -4.5%. Also worth taking note is the 50 day moving average now sits at $51.10 and the 200 day moving average is $46.89. The company has a market cap of 4.33B. The current share price for the company is: 58.37 USD
The potential market cap would be $4,134,584,216 based on the market consensus.
USD
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of -, revenue per share of 10.65 and a -16.81% return on assets.
